Italia markets closed

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
69,20-0,52 (-0,75%)
Alla chiusura: 04:00PM EDT
69,00 -0,20 (-0,29%)
Dopo ore: 07:06PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente69,72
Aperto69,78
Denaro69,10 x 100
Lettera69,31 x 200
Min-Max giorno68,14 - 70,00
Intervallo di 52 settimane45,50 - 76,11
Volume862.282
Media Volume793.518
Capitalizzazione6,699B
Beta (5 anni mensile)1,02
Rapporto PE (ttm)N/D
EPS (ttm)-1,46
Prossima data utili02 mag 2024 - 06 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A83,77
  • GlobeNewswire

    Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference

    NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the 2023 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27, 2023 at 1:15 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

    NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Tuesday, September 12, 2023 at 12:55 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Comp

  • GlobeNewswire

    Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference

    NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023 at 1:30 p.m. ET. The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's websit